4.17
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ACHV?
Forum
Prognose
Aktiensplit
Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
20.68%
5.32
|
6.707 | 7.097 | 7.296 | 7.609 |
| Costs And Expenses |
16.95%
14.69
|
12.56 | 12.89 | 12.19 | 12.47 |
| Depreciation and Amortization |
1.82%
0.054
|
0.055 | 0.062 | 0.058 | 0.057 |
| Nonoperating Income/Loss |
261.94%
0.251
|
-0.155 | 0.067 | -0.17 | -0.046 |
| Income/Loss From Continuing Operations Before Tax |
15.52%
-14.69
|
-12.72 | -12.83 | -12.36 | -12.47 |
| Income/Loss From Continuing Operations After Tax |
13.55%
-14.44
|
-12.72 | -12.83 | -12.36 | -12.51 |
|
|
13.55%
-14.44
|
-12.72 | -12.83 | -12.36 | -12.51 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
47.09%
51.02
|
34.69 | 34.69 | 0.8191 | 34.36 |
| Diluted Average Shares |
47.09%
51.02
|
34.69 | 34.69 | 0.8191 | 34.36 |
| Basic Earnings Per Share |
24.32%
-0.28
|
-0.37 | -0.37 | -0.36 | -0.36 |
| Diluted Earnings Per Share |
24.32%
-0.28
|
-0.37 | -0.37 | -0.36 | -0.36 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):